These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 17267664

  • 21. Protection against cocaine toxicity in mice by the dopamine D3/D2 agonist R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol [(+)-PD 128,907].
    Witkin JM, Dijkstra D, Levant B, Akunne HC, Zapata A, Peters S, Shannon HE, Gasior M.
    J Pharmacol Exp Ther; 2004 Mar; 308(3):957-64. PubMed ID: 14711932
    [Abstract] [Full Text] [Related]

  • 22. The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters through a Rho-Dependent Mechanism.
    Bermingham DP, Hardaway JA, Refai O, Marks CR, Snider SL, Sturgeon SM, Spencer WC, Colbran RJ, Miller DM, Blakely RD.
    J Neurosci; 2017 Sep 20; 37(38):9288-9304. PubMed ID: 28842414
    [Abstract] [Full Text] [Related]

  • 23. Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis.
    Wiesinger JA, Buwen JP, Cifelli CJ, Unger EL, Jones BC, Beard JL.
    J Neurochem; 2007 Jan 20; 100(1):167-79. PubMed ID: 17227437
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux.
    Khoshbouei H, Sen N, Guptaroy B, Johnson L', Lund D, Gnegy ME, Galli A, Javitch JA.
    PLoS Biol; 2004 Mar 20; 2(3):E78. PubMed ID: 15024426
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.
    Johnson LA, Furman CA, Zhang M, Guptaroy B, Gnegy ME.
    Neuropharmacology; 2005 Nov 20; 49(6):750-8. PubMed ID: 16212991
    [Abstract] [Full Text] [Related]

  • 32. Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptor.
    Lecat S, Belemnaba L, Galzi JL, Bucher B.
    Cell Signal; 2015 Jul 20; 27(7):1297-304. PubMed ID: 25817573
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The dopamine D3/D2 agonist (+)-PD-128,907 [(R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol)] protects against acute and cocaine-kindled seizures in mice: further evidence for the involvement of D3 receptors.
    Witkin JM, Levant B, Zapata A, Kaminski R, Gasior M.
    J Pharmacol Exp Ther; 2008 Sep 20; 326(3):930-8. PubMed ID: 18566292
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Activation of P2Y2 receptor induces c-FOS protein through a pathway involving mitogen-activated protein kinases and phosphoinositide 3-kinases in HeLa cells.
    Muscella A, Elia MG, Greco S, Storelli C, Marsigliante S.
    J Cell Physiol; 2003 May 20; 195(2):234-40. PubMed ID: 12652650
    [Abstract] [Full Text] [Related]

  • 39. Linoleic acid induces proinflammatory events in vascular endothelial cells via activation of PI3K/Akt and ERK1/2 signaling.
    Hennig B, Lei W, Arzuaga X, Ghosh DD, Saraswathi V, Toborek M.
    J Nutr Biochem; 2006 Nov 20; 17(11):766-72. PubMed ID: 16563718
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.